Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

BPC-157 / TB-500

Regenerative Synergy & Tissue Healing Charge, S. B. P., & Rudnicki, M. A. (2004). Cellular and Molecular Regulation of Muscle Regeneration. Physiological Reviews, 84(1), 209–238. Malinda, K. M., et al. (1999). Thymosin β4 accelerates wound healing. Journal of Investigative Dermatology, 113(3), 364–368. Sikiric, P., et al. (2010). The stable gastric pentadecapeptide BPC 157: Antiinflammatory and wound healing effects. Current Pharmaceutical Design, 17(16), 1612–1632. Kang, J. W., et al. (2021). Peptide therapy in regenerative medicine: Applications of TB-500 and BPC-157. Journal of Peptide Science, 27(2), e3287. Inflammation Modulation & Pain Reduction 5. Sikiric, P., et al. (2018). BPC 157 as a therapy for inflammatory bowel disease and central/peripheral neuropathy. Current Neuropharmacology, 16(1), 62–71. 6. Philp, D., et al. (2004). Thymosin beta 4 and angiogenesis: Implications for tissue regeneration. Annals of the New York Academy of Sciences, 1112, 42–51. 7. Gou, Y., et al. (202

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Regenerative Synergy & Tissue Healing

Charge, S. B. P., & Rudnicki, M. A. (2004). Cellular and Molecular Regulation of Muscle Regeneration. Physiological Reviews, 84(1), 209–238. Malinda, K. M., et al. (1999). Thymosin β4 accelerates wound healing. Journal of Investigative Dermatology, 113(3), 364–368. Sikiric, P., et al. (2010). The stable gastric pentadecapeptide BPC 157: Antiinflammatory and wound healing effects. Current Pharmaceutical Design, 17(16), 1612–1632. Kang, J. W., et al. (2021). Peptide therapy in regenerative medicine: Applications of TB-500 and BPC-157. Journal of Peptide Science, 27(2), e3287.

Inflammation Modulation & Pain Reduction 5. Sikiric, P., et al. (2018). BPC 157 as a therapy for inflammatory bowel disease and central/peripheral neuropathy. Current Neuropharmacology, 16(1), 62–71. 6. Philp, D., et al. (2004). Thymosin beta 4 and angiogenesis: Implications for tissue regeneration. Annals of the New York Academy of Sciences, 1112, 42–51. 7. Gou, Y., et al. (2022). Inflammatory suppression by BPC-157: Molecular insights. Peptides, 148, 170707.

Vascular & Neural Protection 8. Kovačić, N., et al. (2019). BPC 157 and angiogenesis in healing: Preclinical perspectives. Vascular Pharmacology, 113, 64–75. 9. Zizek, B., et al. (2020). Neuroprotective role of BPC-157 in traumatic brain injury and nerve repair. Brain Research Bulletin, 161, 29–38. 10. Bock-Marquette, I., et al. (2004). Thymosin beta-4 activates integrin-linked kinase in endothelial cells and promotes angiogenesis. Nature, 432(7016), 640–645.

Systemic Recovery & Gut-Brain Axis Support 11. Seiwerth, S., et al. (2018). BPC 157 and organ protection: Gut-brain-healing implications. Regenerative Medicine, 13(4), 321–336. 12. Drmic, D., et al. (2021). BPC 157 therapy in inflammatory, ischemic, and traumatic lesions. Frontiers in Pharmacology, 12, 654125. 13. Tomaszewski, M., et al. (2022). Neuroimmune interactions in recovery: Role of stable gastric peptides. International Journal of Molecular Sciences, 23(12), 6609. 14. Perovic, D., et al. (2019). BPC 157 and gut-liver-brain healing: Emerging clinical targets. Peptides, 113, 85–92.

Recommended Pairings: CJC/Ipamoralin, Healing Stack, “GHK-cu 35mg, TB-500 10mg”

**Note:** This product is intended for research purposes only and not for human consumption. Always consult with a healthcare professional before starting any new supplement or research product.

Connected topics

Follow this recovery question